Abstract
COVID-19, the clinical syndrome caused by SARS-CoV-2, has caused a tremendous burden of global morbidity and mortality. COVID-19 is predicted to have a devastating impact on other global infections, most notably tuberculosis.1 Steep declines in tuberculosis diagnoses are predicted to lead to an excess six million people becoming ill with tuberculosis in the next 5 years and an additional 400 000 tuberculosis-related deaths in 2020 alone.2 Measures taken to control the spread of COVID-19 could have increased tuberculosis transmission in households because people were told to shelter in place at the same time that the most effective infection control measures (ie, rapid diagnosis of tuberculosis and prompt initiation of therapy3) were hampered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
